Method and composition for hyperthermally treating cells
A method and composition for hyperthermally treating tumor cells in a patient under conditions that affect tumor stem cells and tumor cells.
1. A method of enhancing a hyperthermal therapy benefit to a patient in need thereof, the method comprising
selecting at least one nanoparticle among a plurality of nanoparticle types, nanoparticle components, nanoparticle complexes, and nanoparticle compositions;
optionally selecting a therapeutic agent and/or biological agent to be carried by the nanoparticles;
selecting among a plurality of energy types to activate the nanoparticles by electromagnetic radiation;
optionally selecting among additional agents to perform a function separate from that of the activated nanoparticles;
forming a complex and providing therapy to the patient by a method that administers the complex to the patient under conditions to result in improved therapy to the patient by a method that
administers the complex comprising a plurality of nanoparticles and/or quantum dots containing an agent targeting the nanoparticles and/or quantum dots to a site, under conditions sufficient to permit accumulation of the complex at the target site,
provides an energy source at the target site to penetrate the tissue and controllably heat the nanoparticles and/or quantum dots and generate thermal energy to induce a photoacoustic signal or sound wave from the nanoparticles and/or quantum dots,
uses a processor to control the amount of thermal energy delivered at the desired temperature to the target site,
records the temperature and photoacoustic signal or sound wave from the target site or from one or more multiple locations, and
amplifies and processes the recorded photoacoustic signal or sound waves to generate a computational tomographic image of the nanoparticles and/or quantum dots at the target site.
2. The method of claim 1 where the benefit to the patient is selected from the group consisting of a personalized therapy result, an enhanced theranostics capability of an agent to a patient in need thereof, an improvement in a therapy modality, and combinations thereof.
3. The method of claim 1 where a complex of a piezoelectric nanoparticle and a gene is administered to a patient, and an externally-positioned ultrasound source activates the complex to control cell polarization, the method capable of complex activation in the absence of light penetration.
4. The method of claim 3 where activation occurs through at least one of skin, soft tissue, or skull.
5. The method of claim 3 further comprising injecting piezoelectric nanoparticles proximate a peripheral nerve, the nanoparticles containing nerve growth factor, then activating the nanoparticles via an external ultrasound source under conditions sufficient to result in localized electrical stimulation to at least one of a muscle, tendon, joint, or ligament.
6. The method of claim 2 where the personalized or enhanced therapy comprises enhanced cellular uptake, enhanced cellular delivery, enhanced therapy duration, enhanced therapy outcomes, a plurality of therapy effects, and combinations thereof.
7. The method of claim 1 where nanoparticles containing medications and/or genes are administered for use in the method in combination with methods for weakening the cell membrane in order to facilitate influx or delivery of the nanoparticle-contained medications and/or genes into the cell, enhancing delivery and thus enhancing patient therapy.
8. The method of claim 1 where any of microwaves, alternating magnets, radiofrequency waves, or focused ultrasound is applied in conjunction with low dose X-ray radiation therapy, resulting in synergistic thermal and radiation therapy.
9. The method of claim 2 comprising administering nanoparticles that are a combination of gold nanoparticles and magnetic nanoparticles.
10. The method of claim 9 where the nanoparticles contain a magnetic core and a gold shell.
11. The method of claim 10 wherein the gold shell is radioactive.
12. The method of claim 2 where the nanoparticles provide a theranostic capability by
administering targeted nanoparticles, carrying a therapeutic agent, ligated with polymers, and
administering thermotherapy,
assessing the patient's response to the thermotherapy to determine at least one of a qualitative or quantitative change in therapy based on the patient's response, and
changing the therapy to the patient based on the assessment.
13. The method of claim 12 where the therapeutic agent is selected from the group consisting of a medicament, a biologic, and combinations thereof.
14. The method of claim 1 where a nanoparticle/gene complex is administered proximate to an olfactory nerve of a patient, and energy is applied to the complex under conditions sufficient to activate the nanoparticles of the complex to result in brain cell therapy.
15. The method of claim 14 further comprising administering neuronal stem cells with the nanoparticles to enhance or repair neural brain cell function or deficiency.
16. The method of claim 1 further comprising controllably heating the complex at the target site using photoacoustic energy to a temperature of about 40° C.-42° C. to perturb lipid cellular membranes resulting in enhanced penetration of a medicament carried by the complex.
17. The method of claim 1 further comprising administering targeted nanoparticles carrying at least one of pepsin or chymotrypsin resulting in at least one of (a) localized cell membrane perturbation due to enzymatic action, and (b) enhanced patient immune response due to chemotactic action.
18. The method of claim 17 where a tumor cell having a perturbed cellular membrane initiates an immune response that is enhanced relative to an antibody-generated immune response, resulting in enhanced tumor cell damage.